IRIS
ROMEO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.574
AS - Asia 1.499
NA - Nord America 1.301
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 28
OC - Oceania 2
Totale 6.722
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.738
US - Stati Uniti d'America 1.253
SG - Singapore 495
IT - Italia 397
CN - Cina 361
VN - Vietnam 214
BR - Brasile 180
IE - Irlanda 174
HK - Hong Kong 172
KR - Corea 82
DE - Germania 77
JP - Giappone 60
IN - India 47
FR - Francia 39
GB - Regno Unito 32
NL - Olanda 28
AR - Argentina 22
CA - Canada 21
AT - Austria 20
MX - Messico 17
FI - Finlandia 15
BD - Bangladesh 13
ZA - Sudafrica 10
ID - Indonesia 9
EC - Ecuador 8
IQ - Iraq 8
ES - Italia 7
PK - Pakistan 7
PL - Polonia 7
CO - Colombia 6
EG - Egitto 6
GR - Grecia 6
TR - Turchia 6
SE - Svezia 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
MY - Malesia 4
UZ - Uzbekistan 4
BE - Belgio 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 6.629
Salva come PNG Salva come JPEG
Città #
Moscow 962
Singapore 256
San Jose 245
Dublin 172
Hong Kong 167
Santa Clara 141
Ashburn 136
Naples 124
Hefei 90
Ho Chi Minh City 82
Seoul 82
Beijing 64
Chandler 59
Council Bluffs 52
New York 51
Hanoi 47
Dallas 40
Bengaluru 29
Los Angeles 29
Boardman 25
Munich 21
Rome 18
São Paulo 18
Amsterdam 17
Paris 16
Da Nang 15
Orem 15
Boydton 13
Bremen 13
Nuremberg 13
Vienna 13
Milan 12
Princeton 11
Caserta 10
Roxbury 10
Viterbo 10
Atlanta 9
Cambridge 9
Haiphong 9
Mexico City 9
Salerno 9
The Dalles 9
Tokyo 9
Chennai 8
Frankfurt am Main 8
Aversa 7
Falkenstein 7
Memphis 7
Montreal 7
Belo Horizonte 6
Fondi 6
Phoenix 6
Sennori 6
Turku 6
Warsaw 6
Brasília 5
Buffalo 5
Curitiba 5
Des Moines 5
Helsinki 5
Hillsboro 5
Houston 5
Manassas 5
Ninh Bình 5
Pavia 5
Baghdad 4
Biên Hòa 4
Brooklyn 4
Cairo 4
Cesa 4
Chicago 4
Dormagen 4
Hải Dương 4
Jacksonville 4
Johannesburg 4
Lappeenranta 4
London 4
San Francisco 4
Sialkot 4
Tashkent 4
Tianjin 4
Toronto 4
Vũng Tàu 4
Bari 3
Bisaccia 3
Brussels 3
Catania 3
City of London 3
Denver 3
Guayaquil 3
Hangzhou 3
Juneau 3
Lima 3
Manchester 3
Medford 3
Mumbai 3
Nairobi 3
Padova 3
Porto Alegre 3
Pune 3
Totale 3.394
Salva come PNG Salva come JPEG
Nome #
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 181
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 178
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 172
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 168
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 162
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 158
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 146
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 145
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 145
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 142
INTESTINAL MICROBIOTA, INTESTINAL PERMEABILITY AND THE UROGENITAL TRACT: IS THERE A PATHOPHYSIOLOGICAL LINK? 140
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 138
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 137
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 135
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 134
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 131
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 129
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 129
Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study 129
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 129
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 128
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 127
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 127
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 125
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 125
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 117
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 116
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 114
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 114
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 113
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 111
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 109
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 108
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 108
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 106
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 106
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 106
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 103
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 101
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 101
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 101
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 99
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 99
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 99
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 96
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 96
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 94
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 91
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 90
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 88
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 86
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 80
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 80
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic 77
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 28
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 28
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 20
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 14
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 9
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 9
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 6
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives 2
Totale 6.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 6 6 14 15 9 1 0 5 4 27 23
2022/2023348 17 9 6 20 75 17 2 14 156 9 13 10
2023/2024323 19 11 24 29 55 58 9 9 5 10 31 63
2024/2025804 22 16 16 38 119 92 105 91 95 65 81 64
2025/20264.896 209 346 264 183 420 2.565 236 219 156 118 101 79
2026/2027172 37 135 0 0 0 0 0 0 0 0 0 0
Totale 6.722